Phase 2
Completed N=26
Lowering Serum Uric Acid to Prevent Acute Kidney Injury
Source: ClinicalTrials.gov NCT00756964 ↗Enrolled (actual)
26
Serious AEs
0.0%
Results posted
Sep 2012
Primary outcomePrimary: Number of Patients With Acute Kidney Injury (AKI). — 13; 13 Participants
Summary
Acute kidney injury is associated with a rise in serum uric acid during cardiovascular surgery and can cause poor blood flow to the kidneys making them vulnerable to kidney injury. We hypothesize that hyperuricemia, particularly if chronic and marked, is a risk factor for acute kidney injury. The preoperative lowering of serum uric acid will reduce the incidence of acute kidney injury following cardiovascular surgery.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Patients With Acute Kidney Injury (AKI). |
13; 13 | — |
Eligibility Criteria
Inclusion Criteria
- Age 18 years or older, and
- Undergoing elective cardiothoracic surgery(s), alone or in combination with other procedures/surgery(s): thoracic aortic aneurysm, cardiac valves, coronary artery bypass grafting, abdominal thoracic aneurysm, other CV surgery, and
- Preoperative serum uric acid > 6.5 mg/dL, and
- Preoperative estimated glomerular filtration rate of >30ml/min/1.73m2 or higher, but less than 60ml/min/1.73m2
Exclusion Criteria
- Prior history of allergy/adverse reaction to Rasburicase
- History of any organ transplant
- Preoperative intra-aortic balloon pump (IABP)
- Known glucose 6-phosphate dehydrogenase (G6PD) deficiency
- Current use of natriuretic peptides
Data sourced from ClinicalTrials.gov (NCT00756964). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.